Thermo Fisher Scientific TMO Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $9.88B+145% | $4.04B-50.1% | $8.1B-5.2% | $8.54B+90.1% | ||
| $5M-50.0% | $10M+66.7% | $6M-50.0% | $12M-7.7% | ||
| $1.67B+16.1% | $1.44B-0.6% | $1.44B+10.0% | $1.31B+35.5% | ||
| $685M— | —— | —— | —— | ||
| $1.88B+4.1% | $1.8B-12.3% | $2.06B-14.5% | $2.41B+25.1% | ||
| $889M+17.7% | $755M+7.1% | $705M+6.8% | $660M-2.4% | ||
| $28.71B+29.7% | $22.14B-10.0% | $24.59B-2.5% | $25.23B+25.4% | ||
| $10.57B+13.5% | $9.31B-1.5% | $9.45B+1.8% | $9.28B+11.4% | ||
| $49.36B+7.7% | $45.85B+4.2% | $44.02B+6.9% | $41.2B-1.7% | ||
| $1.49B+17.7% | $1.27B-34.0% | $1.92B+342% | $435M+73.3% | ||
| $110.34B+13.4% | $97.32B-1.4% | $98.73B+1.6% | $97.15B+2.1% | ||
| $2.71B-5.0% | $2.85B+6.1% | $2.69B+3.4% | $2.6B-2.0% | ||
| —— | —— | $137M+15.1% | $119M+14.4% | ||
| $15.19B+13.9% | $13.33B-4.9% | $14.01B-17.6% | $17.01B+26.6% | ||
| $39.17B+26.1% | $31.07B-10.5% | $34.73B+1.3% | $34.28B-1.1% | ||
| $213M+5.4% | $202M+6.3% | $190M-9.5% | $210M+5.0% | ||
| $213M+5.4% | $202M+6.3% | $190M-9.5% | $210M+5.0% | ||
| $4.27B+7.1% | $3.99B-14.1% | $4.64B+9.5% | $4.24B-6.7% | ||
| $522M— | —— | —— | —— | ||
| $59.16B+11.4% | $53.1B+12.1% | $47.36B+13.0% | $41.91B+18.3% | ||
| -$2.45B+9.2% | -$2.7B+16.3% | -$3.22B-4.0% | -$3.1B-33.1% | ||
| $22.31B+16.0% | $19.23B+27.0% | $15.13B+25.9% | $12.02B+34.7% | ||
| $53.41B+7.7% | $49.58B+6.1% | $46.74B+6.3% | $43.98B+7.8% | ||
| $110.34B+13.4% | $97.32B-1.4% | $98.73B+1.6% | $97.15B+2.1% | ||
| $147M-15.0% | $173M-10.4% | $193M+2.1% | $189M+26.0% | ||
| $2.66B+9.9% | $2.42B+4.0% | $2.33B-9.5% | $2.57B+4.7% | ||
| $2.61B+33.0% | $1.96B+11.8% | $1.76B+6.9% | $1.64B+0.2% | ||
| $685M— | —— | —— | —— | ||
| $1M-83.3% | $6M+50.0% | $4M-42.9% | $7M-22.2% | ||
| $5.87B+30.7% | $4.49B+1,265% | $329M-24.4% | $435M+73.3% | ||
| $15.84B+2.0% | $15.53B-6.8% | $16.67B-4.4% | $17.44B-13.3% | ||
| $5.87B+30.7% | $4.49B+12.3% | $4B-0.2% | $4.01B-13.6% | ||
| $253M-83.8% | $1.56B+51,933% | $3M— | —— | ||
| $5.87B+30.7% | $4.49B+12.3% | $4B-0.2% | $4.01B-13.6% | ||
| $2B+0.4% | $1.99B+24.6% | $1.6B-23.8% | $2.1B-13.7% | ||
| $1.18B+4.0% | $1.14B-24.1% | $1.5B+27.1% | $1.18B-4.8% | ||
| $2B+0.4% | $1.99B+24.6% | $1.6B-23.8% | $2.1B-13.7% | ||
| $3.33B+4.1% | $3.2B-1.4% | $3.25B-3.2% | $3.35B+13.7% | ||
| $319M— | —— | —— | —— | ||
| $1.18B+4.0% | $1.14B-24.1% | $1.5B+27.1% | $1.18B-4.8% | ||
| $35.85B+23.4% | $29.06B-7.2% | $31.31B+8.3% | $28.91B-10.6% | ||
| $1.18B+4.0% | $1.14B-24.1% | $1.5B+27.1% | $1.18B-4.8% | ||
| $39.46B+25.9% | $31.33B-10.6% | $35.03B+1.4% | $34.56B-1.2% | ||
| $18.56B+3.3% | $17.96B+3.9% | $17.29B+3.2% | $16.74B+3.5% | ||
| $445M+0.2% | $444M+0.5% | $442M+0.2% | $441M+0.5% | ||
| $0— | $0— | $0— | $0— | ||
| $506M— | —— | —— | —— | ||
| $147M-15.0% | $173M-10.4% | $193M+2.1% | $189M+26.0% | ||
| $67M— | —— | —— | —— | ||
| $16M— | —— | —— | —— | ||
| $280M— | —— | —— | —— | ||
| $1.000.0% | $1.000.0% | $1.000.0% | $1.000.0% | ||
| 1.2B0.0% | 1.2B0.0% | 1.2B0.0% | 1.2B0.0% | ||
| 445.2M+0.3% | 443.8M+0.4% | 442.2M+0.3% | 440.7M+0.3% | ||
| $3.53B+59.6% | $2.21B-38.7% | $3.61B-35.3% | $5.58B+120% | ||
| $39.46B+25.9% | $31.33B-10.6% | $35.03B+1.4% | $34.56B-1.2% | ||
| $36.61B+28.3% | $28.53B-11.6% | $32.27B+6.5% | $30.29B-16.0% | ||
| $94M-1.1% | $95M-15.9% | $113M+0.9% | $112M-4.3% | ||
| $194M— | —— | —— | —— | ||
| $1.49B+17.7% | $1.27B-34.0% | $1.92B-32.5% | $2.85B-25.7% | ||
| $366M— | —— | —— | —— | ||
| $319M— | —— | —— | —— | ||
| $685M— | —— | —— | —— | ||
| $506M— | —— | —— | —— | ||
| $506M— | —— | —— | —— | ||
| $187M— | —— | —— | —— | ||
| $319M— | —— | —— | —— | ||
| $103M— | —— | —— | —— | ||
| $35.85B+23.4% | $29.06B-7.2% | $31.31B+8.3% | $28.91B-10.6% | ||
| $7M+121% | -$33M-200% | -$11M-120% | $54M-12.9% | ||
| —— | —— | —— | —— | ||
| $100.000.0% | $100.000.0% | $100.000.0% | $100.000.0% | ||
| 50K0.0% | 50K0.0% | 50K0.0% | 50K0.0% | ||
| 0— | 0— | 0— | 0— | ||
| $122M+1.7% | $120M+1.7% | $118M+1.7% | $116M-4.9% | ||
| $70M+40.0% | $50M-16.7% | $60M+46.3% | $41M+141% | ||
| —— | —— | $26.92B-0.2% | $26.97B-4.7% | ||
| —— | —— | —— | —— | ||
| $250M— | —— | —— | —— | ||
| 68.9M+9.3% | 63.1M+13.5% | 55.5M+10.7% | 50.2M+12.2% | ||
| $419M-20.2% | $525M-2.8% | $540M-5.6% | $572M-49.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Thermo Fisher Scientific's total assets?
- Thermo Fisher Scientific (TMO) holds $113.28B in total assets, up 14.4% year over year.
- How much debt does Thermo Fisher Scientific have?
- Thermo Fisher Scientific carries $43.2B in total debt against $51.9B of shareholders' equity, a debt-to-equity ratio of 0.83.
- How much cash does Thermo Fisher Scientific have?
- Thermo Fisher Scientific holds $3.3B in cash and equivalents.
- Can Thermo Fisher Scientific cover its short-term obligations?
- Its current ratio is 1.53 — current assets exceed current liabilities.
- Where does Thermo Fisher Scientific's balance sheet data come from?
- Every line is extracted from Thermo Fisher Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
